Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Gotwals Philip — Altus Pharmaceuticals Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Gotwals Philip

Gotwals Philip

VP, Program Management at Altus Pharmaceuticals Inc. · on record since Feb 27, 2008

Insider trading activity of Gotwals Philip

Transactions on record: 2; since Jan 11, 2008

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 27, 2008

Figures computed from official regulatory filings — methodology.

Companies where Gotwals Philip has traded

Altus Pharmaceuticals Inc.2 tx · Feb 27, 2008

Track record of Gotwals Philip

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gotwals Philip

Co-insiders of Gotwals Philip

ALDRICH RICHARDAltus Pharmaceuticals Inc.
Altitude Acquisition Holdco LLCAltus Pharmaceuticals Inc.
Attie KennethAltus Pharmaceuticals Inc.
Berkle SheldonAltus Pharmaceuticals Inc.
BLANK BURKHARDAltus Pharmaceuticals Inc.
BNP PARIBAS ARBITRAGE, SAAltus Pharmaceuticals Inc.
Breitling ThomasAltus Pharmaceuticals Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BRUM LYNNE HAltus Pharmaceuticals Inc.

Burstyn Don GAltus Pharmaceuticals Inc.

Connors Timothy JAltus Pharmaceuticals Inc.

FEDERMAN IRWINAltus Pharmaceuticals Inc.

Forrest Richard DAltus Pharmaceuticals Inc.

FUCHS RENATOAltus Pharmaceuticals Inc.

FU WINSTON SAltus Pharmaceuticals Inc.

Galeotos SamAltus Pharmaceuticals Inc.

Gallotto RobertAltus Pharmaceuticals Inc.

GEMAYEL GEORGESAltus Pharmaceuticals Inc.

Griggs FarrisAltus Pharmaceuticals Inc.

HEN STEWARTAltus Pharmaceuticals Inc.

Hosseinion WarrenAltus Pharmaceuticals Inc.

Isaacs Michael GavinAltus Pharmaceuticals Inc.

Kimura AlanAltus Pharmaceuticals Inc.

Klement Gerhard FAltus Pharmaceuticals Inc.

KRAUSZ STEVEN MAltus Pharmaceuticals Inc.

Lanciano Peter LAltus Pharmaceuticals Inc.

LEFF JONATHAN SAltus Pharmaceuticals Inc.

Leicher BruceAltus Pharmaceuticals Inc.

LIDDLE DAVID EAltus Pharmaceuticals Inc.

Lieber Jonathan IAltus Pharmaceuticals Inc.

Margolin Alexey LAltus Pharmaceuticals Inc.

NAVIA MANUELAltus Pharmaceuticals Inc.

NOMURA INTERNATIONAL PLCAltus Pharmaceuticals Inc.

Nomura Phase4 Ventures GP LTDAltus Pharmaceuticals Inc.

Nomura Phase4 Ventures LPAltus Pharmaceuticals Inc.

Nomura Phase4 Ventures LTDAltus Pharmaceuticals Inc.

PENDERGAST DAVID D PHDAltus Pharmaceuticals Inc.

PENNER HARRY JRAltus Pharmaceuticals Inc.

Phair Thomas J.Altus Pharmaceuticals Inc.

Porter JillAltus Pharmaceuticals Inc.

PRESIDIO MANAGEMENT GROUP VIII L L CAltus Pharmaceuticals Inc.

Richard John PAltus Pharmaceuticals Inc.

ROOT JONATHAN DAltus Pharmaceuticals Inc.

Rouf AdeelAltus Pharmaceuticals Inc.

Rust Christopher JAltus Pharmaceuticals Inc.

Sabella Lauren MAltus Pharmaceuticals Inc.

Schubert Kevin MichaelAltus Pharmaceuticals Inc.

Sorvillo John MAltus Pharmaceuticals Inc.

Sturisky HiltonAltus Pharmaceuticals Inc.

Taride Michel MauriceAltus Pharmaceuticals Inc.

Teplis GaryAltus Pharmaceuticals Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Altus Pharmaceuticals Inc.	Feb 27, 2008	AwardD	28,000	0.00	$0	SEC
Altus Pharmaceuticals Inc.	Jan 11, 2008	AwardD	30,000	0.00	$0	SEC